[1] Jia A, Wu Y, Ren W, Han P, Shao Y. Genetic variations of CARMN affect risk of esophageal cancer in northwest China[J]. Gene, 2022,46(748):144680.
[2] Liao Y, Li C, Xia C, et al. Spatial distribution of esophageal cancer mortality in China: a machine learning approach[J]. Int Health. 2021,13(1):70-79.
[3] Cao J, Chen Z, Tian C, et al. A Shared Susceptibility Locus in the p53i> Gene for both Gastric and Esophageal Cancers in a Northwestern Chinese Population[J]. Genet Test Mol Biomarkers. 2020,24(12):804-811.
[4] Baidya K, Devi YS, Rai HK, Devi ND, Sinam N, Kilari GLT. Clinicopathological profile and survival analysis of esophageal carcinoma: A retrospective study in a tertiary care hospital in Northeast India[J]. J Cancer Res Ther. 2024,20(5):1406-1411.
[ 5 ] Liang P, Zhang W, Wang W, e t a l . < i >PLCE1 < / i> Polymorphisms and Risk of Esophageal and Gastric Cancer in a Northwestern Chinese Population[J]. Biomed Res Int. 2019:9765191. Published 2019.
[6] Chen Z, Li M, Ma K, et al. Clinicopathological features and prognosis of patients with esophageal cancer as the second primary cancer: a large population-based analysis using the SEER program [2000-2015]. Transl Cancer Res. 2020,9(2):1113-1124. [ 7 ] Zaidan E P , Tomitão MTP , Pereira M A , e t a l . THYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISMS AND SUSCEPTIBILITY TO ESOPHAGEAL CANCER: A CASE-CONTROL STUDY[M]. Arq Bras Cir Dig. 35:e1684. Published 2022.
[8] Zhao R, Chen X, Ren W, et al. IL-1B rs2853550 polymorphism contributes to esophageal cancer susceptibility in Chinese Han population of Northwest China[J]. Mol Med. 2020,26(1):57. Published 2020 Jun 11.
[9] Watkins R, Soliman GA, Mwaiselage J, Kahesa C, Msami K, Wilson ML. Distance to Health Care Facilities, Lifestyle Risk Factors, and Stage at Diagnosis in relation to Geographic Pattern of Esophageal Cancer in Tanzania, 2006-2016[J]. J Cancer Epidemiol. 2022:7873588.
[10] Ghasemi S, Dreassi E, Khosravi A, Mahaki B. Stomach, Esophageal, and Lung Cancer Mortality Risk and Their Shared Risk Factors in Iran: A County-Level Spatial Analysis[J]. Int J Prev Med. 2024,15:54.
[11] Chen R, Zheng RS, Zhang SW, et al. Analysis of incidence and mortality of esophageal cancer in China, 2015. Zhonghua Yu Fang Yi Xue Za Zhi. 2019,53(11):1094-1097.
[12] He F, Wang J, Liu L, et al. Esophageal cancer: trends in incidence and mortality in China from 2005 to 2015[J]. Cancer Med. 2021,10(5):1839-1847.
[13] Chen R, Zheng R, Zhang S, et al. Patterns and trends in esophageal cancer incidence and mortality in China: An analysis based on cancer registry data[J]. J Natl Cancer Cent. 2023,3(1):21-27.
[14] Xie SH, Chen R, Zhao DL, et al. Status of non-steroidal anti-inflammatory drugs use in areas with a high incidence of upper gastrointestinal cancer in China: a multi-center crosssectional survey[J]. Cancer Med. 2019,53(11):1098-1103.
[15] Yu D, Ou Z, Zhang W, et al. Global and national trends in years of life lost and years lived with disability caused by three common gastrointestinal cancers from 1990 to 2019[J]. BMC Gastroenterol. 2022,22(1):493.
[16] Jubashi A, Kotani D, Kojima T, Takebe N, Shitara K. Current landscape of targeted therapy in esophageal squamous cell carcinoma[J]. Curr Probl Cancer. 2023,53(1):101152.
[17] Li H, Yang X, Zhang A, Liang G, Sun Y, Zhang J. Age-period-cohort analysis of incidence, mortality and disabilityadjusted life years of esophageal cancer in global, regional and national regions from 1990 to 2019[J]. BMC Public Health. 2024,24(1):212. [18] Ito R, Kadota T, Murano T, et al. Clinical features and risk factors of gastric cancer detected by esophagogastroduodenoscopy in esophageal cancer patients[J]. Esophagus. 2021,18(3):621-628.
[19] Xu YH, Lu P, Gao MC, Wang R, Li YY, Song JX. Progress of magnetic resonance imaging radiomics in preoperative lymph node diagnosis of esophageal cancer[J]. World J Radiol. 2023,15(7):216-225.
[20] Zhu C, Sun W, Chen C, et al. Prediction of malignant esophageal fistula in esophageal cancer using a radiomics-clinical nomogram[J]. Eur J Med Res. 2024,29(1):217.
[21] Lichtenberger J P 3rd , Zeman M N, Dulberger A R, Alqutub S, Carter BW, Manning MA. Esophageal Neoplasms: Radiologic-Pathologic Correlation[J]. Radiol Clin North Am. 2021,59(2):205-217.
[22] Xi Y, Dong W, Qiao L, Han K, Chen W, Wang W. Trends in incidence and mortality of esophageal cancer in Inner Mongolia, 2010-2015[J]. Thorac Cancer. 2020,11(9):2440-2448.
[23] Jin X, Zhou Q, Lyu B, Zhang C, Huang L. Ability of detection in different resolution endoscopy for upper gastrointestinal mucosal lesions[J]. Surg Endosc. 2024,38(10):5903-5913.
[24] Akkus Gunduz P, Ozkan E, Kuru Oz D, et al. Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: a prospective study[J]. Nucl Med Commun. 2023,44(2):150-160.
[25] Yoon JK, Han DH, Lee S, et al. Intraindividual comparison of prognostic imaging features of HCCs between MRIs with extracellular and hepatobiliary contrast agents[J]. Liver Int. 2024,44(10):2847-2857.
[26] Rezaei N, Sharafkhah M, Farahmand Y, et al. Population attributable fractions of cancer mortality related to indoor air pollution, animal contact, and water source as environmental risk factors: Findings from the Golestan Cohort Study[J]. PLoS One. 2024,19(6):e0304828.
[27] Alijani F, Khoshnazar SM, Eslami O. Examining the Frequency of Second Endoscopy and Its Effect on Patient Outcomes With Upper Gastrointestinal Bleeding in Southeast of Iran[J]. Surg Laparosc Endosc Percutan Tech. 2024,34(3):314-320.
[28] Liu LL, Han L, Han YG, Gao Y, Peng L. Spatio-temporal variations of aridity index and its response to climate factors in Northwest China during 1989-2019[J]. Ying Yong Sheng Tai Xue Bao. 2021,32(11):4050-4058.
[29] Rao Z, Xie X, Tang X, et al. The spatiotemporalcorrelation of PM2.5 concentration on esophageal cancer hospitalization rate in Fujian province of China[J]. Environ Sci Pollut Res Int. 2022,29(44):67325-67335.
[30] Ji Z, Tian S. A novel potential cause of extreme precipitation in the northwest China[J]. Heliyon. 2024,10(9):e30826.
[31] Si L, Wang P, Cao D. Towards sustainable development goals: Assessment of wind and solar potential in northwest China[J]. Environ Res. 2024,252(Pt 3):118660.
[32] Sui X, Xu Q, Tao H, Zhu B, Li G, Zhang Z. Vegetation Dynamics and Recovery Potential in Arid and Semi-Arid Northwest China[J]. Plants (Basel). 2024,13(23):15-23.
[33] Zhang L N, Song Y T, Jiang L, Zhu R X, L i L. Polymorphism and Forensic Application Value of 71 Y-SNP Loci in Han Population of Northwest China[J]. Fa Yi Xue Za Zhi. 2019,35(1):23-29.
[34] Ren J, Yang J, Wu F, Sun W, Xiao X, Xia JC. Regional thermal environment changes: Integration of satellite data and land use/land cover. iScience[J]. 2023,26(2):105820.
[35] Ren J, Yang D. Two new species of Limonia Meigen, 1803 from Northwest China (Diptera, Limoniidae)[J]. Zookeys. 2024,971:31-58.
[36] Liu Z, Zhao C, Du S, Gao S, Lu L. MiR-4262 inhibits the development of esophageal cancer by negatively regulating KLF6 level[J]. Exp Mol Pathol. 2021,38(115):104476.
[37] Liu CC, Chou KT, Hsu JW, et al. High metabolic rate and stem cell characteristics of esophageal cancer stem-like cells depend on the Hsp27-AKT-HK2 pathway[J]. Int J Cancer. 2019,145(8):2144-2156.
[38] Yang H, Wang JB, Wang XK, Fan JH, Qiao YL. Association between type o f drinking water and upper gastrointestinal cancer incidence i n the Linxian General Population[J]. BMC Cancer. 2023,23(1):397.
[39] Han Y, Zhu X, Hu Y, et al. Electronic Health RecordBased Absolute Risk Prediction Model for Esophageal Cancer in the Chinese Population: Model Development and External Validation[J]. JMIR Public Health Surveill. 2024,9:e43725.
[40] Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study[J]. Lancet Reg Health Southeast Asia. 2023,21:100333.